Long-Term Follow-Up of Recipient of Gene Transfer Research

Recruiting now

Conditions studied: Retroviridae Infections, Cancer

In brief

The goal of this clinical research study is to collect information about the long-term safety of gene transfer therapy. This study is also designed to create a database of medical information about patients who have received gene transfer therapy, in order for researchers to track and review the long-term safety and any effects (good or bad) of gene transfer therapy.

Key facts

Study ID

NCT01492036

Run by

M.D. Anderson Cancer Center

People needed

130

Starts

2011-12-09

Expected to finish

2027-12-31

Last updated by the study team

2026-07-15

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Patient or patient's legal representative(s) provided written informed consent to participate in a gene transfer study at the University of Texas MD Anderson Cancer Center (MD Anderson).
• Patient will receive vector or vector-treated cells at MD Anderson.
• Patient or patient's legal representative(s) is/are able to provide written informed consent to participate in this long-term follow-up protocol for gene transfer participants for up to 15 years following administration of gene therapy product.
• Agree to allow clinical samples to be collected and stored at MD Anderson and/or at a NIH designated facility such as the NGVB.

You may not qualify if…

• Subject's gene transfer protocol is not approved at MD Anderson Cancer Center.

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.